CureVac says mass vaccine rollout thrown into doubt by US restrictions
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
SUNDAY, MAY 22, 2022
SUNDAY, MAY 22, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
CureVac says mass vaccine rollout thrown into doubt by US restrictions

Coronavirus chronicle

Reuters
04 May, 2021, 09:30 pm
Last modified: 04 May, 2021, 09:33 pm

Related News

  • Covax calls for urgent action to close vaccine equity gap
  • Main negotiators reach 'outcome' on Covid vaccine IP waiver, WTO says
  • Britain approves Valneva's easy-to-store Covid shot
  • 95% of target population fully vaccinated: Health Minister
  • Help all reach vaccination targets, Hasina urges COVAX summit

CureVac says mass vaccine rollout thrown into doubt by US restrictions

"Due to the Defense Production Act we are not getting certain goods out of the USA," CureVac Chief Executive Franz-Werner Haas said

Reuters
04 May, 2021, 09:30 pm
Last modified: 04 May, 2021, 09:33 pm
Representational Image. Photo: Reuters
Representational Image. Photo: Reuters

Germany's CureVac, which is gearing up to publish results of a key Covid-19 vaccine trial, said US export restrictions on key materials are making it impossible to predict its short-term supply ramp-up in Europe.

"Due to the Defense Production Act we are not getting certain goods out of the USA," CureVac Chief Executive Franz-Werner Haas told weekly Der Spiegel.

The Defense Production Act is a decades old US law that gives federal agencies the power to prioritize procurement orders related to national defence, but it has also widely been used in non-military crises such as natural disasters.

"We are not getting all the materials that we need," he was quoted as saying.

"At times we live from hand to mouth. That makes it hard to build up a stockpile," Haas said, when asked how much the company would be able to deliver during the summer months.

He added that items in short supply include special plastic containers and nucleotides, which are the chemical building blocks that make up the genetic code in the vaccine's active ingredient, the so-called messenger RNA.

Unlike rival German vaccine developer BioNTech, which struck a partnership with pharma giant Pfizer, CureVac has not teamed up with a US partner. BioNTech and Pfizer continue to increase global production and have not cited the Defense Production Act as a hindrance.

As CureVac's only major supply deals, the European Union in November last year secured up to 405 million doses of the immunisation. 

The biotech firm has said it expects to file for European authorization in late May or early June.

Nasdaq-listed CureVac, which is backed by investors Dietmar Hopp, GlaxoSmithKline as well as the German government, has said it aims to produce up to 300 million doses of the vaccine in 2021 and up to 1 billion in 2022.

Top News

CureVac / covid-19 vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Project delays: The Sinohydro style 
    Project delays: The Sinohydro style 
  • An image created during an investigation into an outbreak of monkeypox, which took place in the Democratic Republic of the Congo (DRC), 1996 to 1997, shows the hands of a patient with a rash due to monkeypox.(REUTERS)
    WHO expects more cases of monkeypox to emerge globally
  • Photo: Courtesy
    Misfit Technologies: A Singaporean startup rooted firmly in Bangladesh

MOST VIEWED

  • People wearing protective face masks walk on a street, following new cases of the coronavirus disease (Covid-19), in Shanghai, China August 25, 2021. REUTERS/Aly Song
    Shanghai district to require all shops to shut, residents to stay home
  • Photo: Courtesy
    Covax calls for urgent action to close vaccine equity gap
  • Photo: BSS/AFP
    Covax calls for urgent action to close vaccine equity gap
  • Photo: Collected
    Thousands of Covid-negative Beijing residents sent to quarantine
  • A man checks phone at Lujiazui financial district in Pudong, Shanghai, China March 14, 2019. Photo :Reuters
    Shanghai inches towards Covid lockdown exit, Beijing plays defence
  • North Korean leader Kim Jong Un delivers opening remarks during the 2nd Conference of Secretaries of Primary Committees of the Workers' Party of Korea (WPK), in this photo released on February 27, 2022 by North Korea's Korean Central News Agency (KCNA). KCNA via REUTERS/File Photo
    N Korea reports over 200,000 fever cases for 5th day amid Covid wave

Related News

  • Covax calls for urgent action to close vaccine equity gap
  • Main negotiators reach 'outcome' on Covid vaccine IP waiver, WTO says
  • Britain approves Valneva's easy-to-store Covid shot
  • 95% of target population fully vaccinated: Health Minister
  • Help all reach vaccination targets, Hasina urges COVAX summit

Features

Warah uses three types of khadi material: a sheer and light one, a medium count and a thicker one.

Warah: Embroidered with culture and womanhood

1h | Mode
Photo: Courtesy

Misfit Technologies: A Singaporean startup rooted firmly in Bangladesh

1h | Panorama
The Buffalo shooter targeted Black people, linking mass migration with environmental degradation and other eco-fascist ideas. Photo: Reuters

Eco-fascism: The greenwashing of the far right

20h | Panorama
Green-backed Heron on a tilting stalk. Photo: Enam Ul Haque

Green-backed Heron: Nothing but a prayer to catch a fish  

23h | Panorama

More Videos from TBS

CV or Resume: Which one to create for job application

CV or Resume: Which one to create for job application

46m | Videos
Wheat prices double in India

Wheat prices double in India

14h | Videos
Is Washington-Moscow agreement possible?

Is Washington-Moscow agreement possible?

15h | Videos
Pigeon exhibition for the first time in Gazipur

Pigeon exhibition for the first time in Gazipur

19h | Videos

Most Read

1
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

2
A packet of US five-dollar bills is inspected at the Bureau of Engraving and Printing in Washington March 26, 2015. REUTERS/Gary Cameron
Banking

Dollar hits Tk100 mark in open market

3
The story of Bangladesh becoming a major bicycle exporter
Industry

The story of Bangladesh becoming a major bicycle exporter

4
PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire
Crime

PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire

5
BSEC launches probe against Abul Khayer Hero and allies
Stocks

BSEC launches probe against Abul Khayer Hero and allies

6
The reception is a volumetric box-shaped room that has two glass walls on both the front and back ends and the other two walls are adorned with interior plants, wood and aluminium screens. Photo: Noor-A-Alam
Habitat

The United House: Living and working inside nature

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab